Oculis Rings the Opening Bell

About This Event

Oculis Holding AG (Nasdaq: OCS) ("Oculis"), a global biopharmaceutical company purposefully driven to save sight and improve eye care, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Riad Sherif, MD, CEO of Oculis, rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore